Skip to content

Prospective, randomized controlled study of intrauterine use of platelet-rich plasma to improve prognosis in patients with intrauterine adhesions

Prospective, randomized controlled study of intrauterine use of platelet-rich plasma to improve prognosis in patients with intrauterine adhesions

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065764
Enrollment
Unknown
Registered
2022-11-14
Start date
2020-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unterine adhesion

Interventions

Intervention group:platelet rich plasma+COOK baloon
Control group:COOK baloon

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-37 years, women with childbearing requirements; 2. The number of previous uterine adhesions operation<=2; 3. Those who have not participated in any clinical trials within the last three months; 4. Voluntary signatories of informed consent.

Exclusion criteria

Exclusion criteria: 1. Endocrine metabolic diseases, such as diabetes mellitus, insulin resistance, hyperthyroidism, Cushing's syndrome, hyperprolactinemia, polycystic ovary syndrome; 2. Complicated with endometrial lesions, such as endometrial tuberculosis, endometrial polyps, uterine submucosal myoma, endometrial hyperplasia; 3. Clearly diagnosed autoimmune diseases, such as systemic lupus erythematosus, Sjogren's syndrome, Hashimoto's thyroiditis, multiple sclerosis, rheumatoid arthritis, autoimmune hemolytic anemia, recurrent abortion; 4. Ovarian masses >=4cm in diameter that have not been surgically defined; 5. Combined with adenomyosis of uterus, B-ultrasound showed ovarian endometriosis cyst >=4cm; All kinds of neoplastic malignant diseases or precancerous lesions; 6. Untreated hydrosalpinx.

Design outcomes

Primary

MeasureTime frame
implantation rate;clinical pregnancy rate;

Secondary

MeasureTime frame
occurence of adhesions;early abortion rate;

Countries

China

Contacts

Public ContactLi Manchao

The Sixth Affiliated Hospital of Sun Yat-sen University

9253396@qq.com+86 18312025840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026